featured
Safety and Efficacy of Valbenazine for the Treatment of Chorea Associated With Huntington's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
Lancet Neurol 2023 Jun 01;22(6)494-504, EF Stimming, DO Claassen, E Kayson, J Goldstein, R Mehanna, H Zhang, GS Liang, D HaubenbergerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.